Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Added to OROS Methylphenidate for ADHD and Aggression
NCT00550147Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Feb 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in attention deficit hyperactivity disorder (ADHD), conduct disorder (CD), sponsored by Indiana University School of Medicine. Started Feb 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
attention deficit hyperactivity disorder (ADHD)conduct disorder (CD)
Beyond the preview
Go deeper on NCT00550147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550147.